Td Private Client Wealth LLC Halozyme Therapeutics, Inc. Transaction History
Td Private Client Wealth LLC
- $3.48 Trillion
- Q3 2024
A detailed history of Td Private Client Wealth LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 38 shares of HALO stock, worth $1,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 22
72.73%
Holding current value
$1,862
Previous $1.15 Million
88.8%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$863 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$632 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$325 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$199 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$167 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.83B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...